Struwe Ellen, Berzl Gabriele M, Schild Ralf L, Dötsch Jörg
Department of Pediatrics, University Hospital of Erlangen-Nuremberg, Germany.
Eur J Obstet Gynecol Reprod Biol. 2009 Jan;142(1):38-42. doi: 10.1016/j.ejogrb.2008.08.007. Epub 2008 Nov 11.
Fetal growth restriction is associated with an increased risk for metabolic and cardiovascular disease in later life. To further elucidate mechanisms that might be involved in the process of prenatal programming, we measured the adipokines leptin, resistin, and adiponectin and the GH-releasing hormone ghrelin in the placenta of small for gestational age (SGA) neonates.
The control group included 24 placentas of appropriate for gestational age (AGA) newborns, in the study group were 16 placentas of SGA neonates. Gene expression of leptin, resistin, adiponectin, and ghrelin was examined. For hormones showing alterations in gene regulation placental protein expression was measured by Western blot.
Placental mRNA expression of leptin was significantly increased in SGA placentas (p=0.0035, related to beta-actin). Protein concentration was increased, as well. There were no differences in placental resistin, adiponectin, or ghrelin gene expressions between SGA neonates and controls. Leptin was the only hormone to demonstrate a significant inverse correlation with birth weight (r=-0.44, p=0.01). Adiponectin correlated significantly with leptin (r=0.53, p=0.0023) and ghrelin (r=0.50, p=0.0045).
Placental leptin gene expression and protein concentration showed the expected increase in the SGA group. Leptin was inversely correlated with birth weight. Positive correlation of adiponectin with leptin and ghrelin expression suggests an interaction between these hormones in the placenta. However, the unchanged expression of resistin, adiponectin, and ghrelin in SGA placentas and the absence of correlation with birth weight cast doubt whether these hormones produced in the placenta play a key role in fetal programming.
胎儿生长受限与日后发生代谢和心血管疾病的风险增加相关。为了进一步阐明可能参与产前编程过程的机制,我们测量了小于胎龄(SGA)新生儿胎盘内的脂肪因子瘦素、抵抗素、脂联素以及生长激素释放激素胃饥饿素。
对照组包括24例适于胎龄(AGA)新生儿的胎盘,研究组为16例SGA新生儿的胎盘。检测了瘦素、抵抗素、脂联素和胃饥饿素的基因表达。对于基因调控发生改变的激素,通过蛋白质印迹法测量胎盘蛋白表达。
SGA胎盘内瘦素的胎盘mRNA表达显著增加(p = 0.0035,相对于β-肌动蛋白)。蛋白浓度也升高。SGA新生儿与对照组之间胎盘抵抗素、脂联素或胃饥饿素基因表达无差异。瘦素是唯一与出生体重呈显著负相关的激素(r = -0.44,p = 0.01)。脂联素与瘦素(r = 0.53,p = 0.0023)和胃饥饿素(r = 0.50,p = 0.0045)显著相关。
SGA组中胎盘瘦素基因表达和蛋白浓度呈现预期的增加。瘦素与出生体重呈负相关。脂联素与瘦素和胃饥饿素表达的正相关表明这些激素在胎盘中存在相互作用。然而,SGA胎盘中抵抗素、脂联素和胃饥饿素表达未改变且与出生体重无相关性,这使人怀疑胎盘中产生的这些激素在胎儿编程中是否起关键作用。